2021, Number 3
Complications of simple open prostatectomy in geriatric patients
Language: Spanish
References: 25
Page:
PDF size: 585.38 Kb.
ABSTRACT
Introduction: Adenoma exeresis is the surgical treatment recommended for patients with prostatic hyperplasia.Objective: Evaluate the complications of simple open prostatectomy in geriatric patients.
Methods: An observational retrospective longitudinal descriptive study was conducted of 106 geriatric patients undergoing open surgery for benign prostatic hyperplasia at Comandante Manuel Fajardo Clinical Surgical University Hospital in the period 2012-2017. The sample was divided into two groups: retropubic and transvesical surgery. Summary measurements, mean and standard deviation were estimated for quantitative variables and percentages for qualitative variables. The X2 test was used to establish associations, and the non-parametric mean comparison test was applied to independent samples. Multivariate analysis was performed to estimate the risk factors for complications. A p value ˂ 0.05 was considered.
Results: Mean age was 74 years. Of the patients studied, 68.9% had comorbidities, with a predominance of ASA II (58.4%), patients with severe and moderate obstructive symptoms (86.9%), and quality-of-life-related effects (71.7%). 30.1% presented complications, mostly postoperative and grade I, with no differences between retropubic and transvesical surgery. Complications were not associated to age. Identification was made of risk factors for the occurrence of complications.
Conclusions: Postoperative complications prevailed. Renal damage, pharmacological treatment failure, preoperative urinary infection, hospital stay and surgical time were identified as the risk factors causing the complications.
REFERENCES
Pérez Santos LG, Torres Hernández RM, Silva Cañetas CS, González Jiménez B, Hernández Ojeda H. Morbimortalidad con una técnica de empaquetamiento en cirugía de próstata. Rev Mex Med Forense .2019 [acceso 14/01/2020];4(1):24-35. Disponible en: https://www.medigraphic.com/pdfs/forense/mmf-2019/mmf191c.pdf
Rensing AJ, Kuxhausen A, Vetter J, Strope SA. Differences in the treatment of benign prostatic hyperplasia: comparing the Primary Care Physician and the Urologist. Urol Pract. 2018 [acceso 14/01/2020];4(3):193-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451141/pdf/nihms823221.pdf
Bai F, Feng S, Xu C, Xu Z, Chen J, Zheng Y. Transurethral resection versus holmium laser enucleation of the prostate: A prospective randomized trial comparing perioperative thrombin generation and fibrinolysis. Medicine (Baltimore). 2019 [acceso 14/01/2020];98(15):e15223. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485898/pdf/medi-98-e15223.pdf
Lokeshwar SD, Harper BT, Webb E, Jordan A, Dykes TA, Neal DE Jr. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol .2019 [acceso 07/02/2021];8(5):529-39. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842780/pdf/tau-08-05-529.pdf
Gravas S, Cornu JN, Drake MJ, Gacci M, Gratzke C, Herrmann TRW, et al. Management of non-neurogenic male lower urinary tract symptoms (LUTS), benign prostatic obstruction (BPO). Europ Assoc Urol. 2018 [acceso 14/01/2020]. Disponible en: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-the-Management-of-Non-neurogenic-Male-LUTS-2018-large-text.pdf
Nickel JC, Aaron L, Barkin J, Elterman D, Nachabé M, Zorn KC. Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update. Can Urol Assoc J .2018 [acceso 04/01/2020];12(10):303-12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192748/pdf/cuaj-10-303.pdf
Carneiro A, Sakuramoto P, Wroclawski ML, Forseto PH, Den Julio A, Bautzer CR. Open suprapubic versus retropubic prostatectomy in the treatment of benign prostatic hyperplasia during resident's learning curve: a randomized controlled trial. Int Braz J Urol .2016 [acceso 14/01/2020];4 2(2):284-92. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871389/pdf/1677-5538-ibju-42-02-0284.pdf
Marmiroli R, Antunes AA, Reis ST, Nakano E, Srougi M. Standard surgical treatment for benign prostatic hyperplasia is safe for patients over 75 years: analysis of 100 cases from a high-volume urologic center. Clinics (Sao Paulo). 2012 [acceso 14/01/2020];67(12):1415-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521804/pdf/cln-67-12-1415.pdf
Matta R, Dvorani E, Wallis C, Hird A, La Bossiere J, Kulkarni G, et al. Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada. BMJ Open. 2019 [acceso 14/01/2020];9(12):e032170. Disponible en: https://bmjopen.bmj.com/content/bmjopen/9/12/e032170.full.pdf